Lawrence Lamb
Has grant
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Lawrence Lamb is the Chief Scientific Officer at IN8Bio in the United States. His research primarily focuses on the mechanisms of enhancing immune responses in cancer treatment, particularly through the use of novel therapeutic combinations. Recent articles authored by him explore the synergistic effects of Temozolomide and Niraparib on immune cell activation in glioblastoma.
Recent Grants
Grant: Close
Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multif
Open Date: 2010-03-01
Close Date: 2012-02-28
Grant: Close
Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multif
Open Date: 2010-03-01
Close Date: 2012-02-28
Grant: Close
Feasibility of gamma/delta T cell immunotherapy for glioblastoma
Open Date: 2007-09-01
Close Date: 2010-07-31
Grant: Close
Feasibility of gamma/delta T cell immunotherapy for glioblastoma
Open Date: 2007-09-01
Close Date: 2010-07-31
Grant: Close
BD Biosciences FACS Canto Flow Cytometer
Open Date: 2006-04-01
Close Date: 2007-03-31
Articles (1)
Year:
2024
Collaborators (1)
Elizabeth Beierle
Professor of Surgery
The University of Alabama at Birmingham School of Medicine
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.